-
Mashup Score: 1Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer - 4 year(s) ago
Genetic inactivation of PTEN is common in prostate cancer and correlates with poorer prognosis. We previously identified CHD1 as an essential gene in PTEN-deficient cancer cells. Here, we sought definitive in vivo genetic evidence for, and mechanistic understanding of, the essential role of CHD1 in PTEN-deficient prostate cancer. In Pten and Pten / Smad4 genetically engineered mouse models,…
Source: Cancer DiscoveryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Making Your Treatment Decision - Prostate Cancer Patient Interview with Andy Schwartz - 4 year(s) ago
(Length of Interview: 2 min) Andy Schwartz, a prostate cancer advocate, and survivor answers a series of questions and explains the importance of seeking information to better prepare yourself for prostate cancer treatment. 1. How did you go about making your treatment decision? 2. Did you feel that you had an adequate understanding of all the pros and cons of each treatment that was available…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Making your treatment decision - #ProstateCancer patient interview. Andy Schwartz explains the importance of seeking information to better prepare yourself for prostate cancer treatment. #WatchNow > https://t.co/Ys4HQRvcPZ #ProstateCancerAwareness @UCSFCancer @charlesryanmd #PCAM https://t.co/MVgHpEyAL0
-
-
Mashup Score: 0SEA Blue 2020 - 4 year(s) ago
Help support Us TOO International today!
Source: ustoo.rallybound.orgCategories: General Medicine News, Latest HeadlinesTweet-
This year's 2020 National @SEABlueWalkRun is going virtual Sept 13th! @LoebStacy, @CaPsurvivorship, @DrAdamMurphy & @uroegg will answer registrants' questions. #RegisterNow > https://t.co/fSlvvshYB4 and dont't miss out! #ProstateCancerAwareness #PCAM https://t.co/tIENJ0j1Up
-
-
Mashup Score: 0Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment - PubMed - 4 year(s) ago
We report a significant increasing rate of fatal prostate cancer incidence among English men. The black-white racial disparity appears pervasive but is attenuated among those who received radical prostatectomy in the US.
Source: PubMedCategories: Genetics, Latest HeadlinesTweet-
Study in @BrJCancer reports #ProstateCancer rates are drastically increasing in England while declining in the US. Racial differences are evident in both countries and projected to remain. @michaelbcook @EBeezy360 #NCI_MetabolicEpi #ProstateCancerAwareness https://t.co/L1diLr81l0 https://t.co/F2xlOxDPIN
-
-
Mashup Score: 3
Dr. Berndt utilizes new analytic methods in genetic and molecular epidemiology to elucidate the etiology of cancer and anthropometric traits and explores the impact of modifiable risk factors on cancer risk and mortality.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet-
Dr. Sonja Berndt studies the genetic susceptibility and environmental risk factors for #prostatecancer and examines how they may be used in risk prediction and screening https://t.co/DiRk4Qk507 #ProstateCancerAwareness https://t.co/ZAZeIN9WVg
-
-
Mashup Score: 0
ESMO 2020 causes of racial disparities in deaths following prostate cancer surgery, rate of developing prostate cancer, disparities in prostate cancer survival among different groups, factors contributing to racial disparities in cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Study highlights possible causes of #RacialDisparities in #ProstateCancer deaths following surgery. Findings published in @JournalCancer. #ReadNow details on UroToday > https://t.co/PAljdqGAy5 @AmericanCancer @VUmedicine #ProstateCancerAwareness https://t.co/78AtFBJSsF
-
-
Mashup Score: 0SEA Blue 2020 - 4 year(s) ago
Help support Us TOO International today!
Source: ustoo.rallybound.orgCategories: General Medicine News, Latest HeadlinesTweet-
This year's 2020 National @SEABlueWalkRun is going virtual Sept 13th! @LoebStacy, @CaPsurvivorship, @DrAdamMurphy & @uroegg will answer registrants' questions. #RegisterNow > https://t.co/fSlvvshYB4 and dont't miss out! #ProstateCancerAwareness #PCAM https://t.co/tIENJ0j1Up
-
-
Mashup Score: 0Making Your Treatment Decision - Prostate Cancer Patient Interview with Andy Schwartz - 4 year(s) ago
(Length of Interview: 2 min) Andy Schwartz, a prostate cancer advocate, and survivor answers a series of questions and explains the importance of seeking information to better prepare yourself for prostate cancer treatment. 1. How did you go about making your treatment decision? 2. Did you feel that you had an adequate understanding of all the pros and cons of each treatment that was available…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Making your treatment decision - #ProstateCancer patient interview. Andy Schwartz explains the importance of seeking information to better prepare yourself for prostate cancer treatment. #WatchNow > https://t.co/Ys4HQRvcPZ #ProstateCancerAwareness @UCSFCancer @charlesryanmd #PCAM https://t.co/AuvRTzhPgr
-
-
Mashup Score: 0SEA Blue 2020 - 4 year(s) ago
Help support Us TOO International today!
Source: ustoo.rallybound.orgCategories: General Medicine News, Latest HeadlinesTweet-
This year's 2020 National @SEABlueWalkRun is going virtual Sept 13th! @LoebStacy, @CaPsurvivorship, @DrAdamMurphy & @uroegg will answer registrants' questions. #RegisterNow > https://t.co/fSlvvshYB4 and dont't miss out! #ProstateCancerAwareness #PCAM https://t.co/tIENJ0j1Up
-
-
Mashup Score: 0Prostate Cancer - Statistics - 4 year(s) ago
ON THIS PAGE: You will find information about the number of people who are diagnosed with prostate cancer each year. You will also read general information on surviving the disease. Remember, survival rates depend on several factors. Use the menu to see other pages.Prostate cancer is the most common cancer among men, except for skin cancer. This year, an estimated 191,930 men in the United States…
Source: Cancer.NetCategories: Hem/Oncs, Latest HeadlinesTweet-
September is #ProstateCancerAwareness Month! Prostate cancer is the most common cancer among men, except for skin cancer. This yr., an estimated 191,930 men in the US will be diagnosed with prostate cancer. To learn more visit & follow @CancerDotNet https://t.co/VKkmfJhx1W https://t.co/Bg6XfJFWyf
-
In recognition of #ProstateCancerAwareness month: From the September issue— The #chromatin regulator CHD1 remodels the immunosuppressive tumor microenvironment in PTEN-deficient #ProstateCancer. @Dr_Di_Zhao @RonDePinho @YAlanWang #immunotherapy https://t.co/zTDNT26vNl https://t.co/aOHBIW7eyQ